Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Central University of Venezuela · Consejo Superior de Investigaciones Científicas · +6 more institutions
Abstract
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system. Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clinical resistance, e.g., in North Bihar in India. In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss…
Citation impact
- FWCI
- 67.78
- Percentile
- 100%
- References
- 142
Authors
9- APAlicia Ponte‐SucreCorresponding
Central University of Venezuela
- FGFrancisco Gamarro
Consejo Superior de Investigaciones Científicas, Instituto de Parasitología y Biomedicina "López - Neyra"
- JDJean‐Claude Dujardin
Instituut voor Tropische Geneeskunde
- MPMichael P. Barrett
Wellcome Centre for Molecular Parasitology, University of Glasgow
- RLRogelio López‐Vélez
Topics & keywords
- Miltefosine
- Visceral leishmaniasis
- Leishmaniasis
- Drug resistance
- Medicine
- Leishmania
- Leishmania donovani
- Drug
- Good health and well-being